Multisomatoform disorder. An alternative to undifferentiated somatoform disorder for the somatizing patient in primary care

scientific article

Multisomatoform disorder. An alternative to undifferentiated somatoform disorder for the somatizing patient in primary care is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1001/ARCHPSYC.1997.01830160080011
P698PubMed publication ID9107152
P5875ResearchGate publication ID14110936

P50authorJanet B. W. WilliamsQ72206056
Robert SpitzerQ653207
P2093author name stringLinzer M
Kroenke K
Davies M
Brody D
deGruy FV 3rd
Hahn SR
P433issue4
P407language of work or nameEnglishQ1860
P921main subjectpatientQ181600
somatoform disorderQ936549
undifferentiated somatoform disorderQ1858000
P1104number of pages7
P304page(s)352-358
P577publication date1997-04-01
P1433published inJAMA PsychiatryQ635830
P1476titleMultisomatoform disorder. An alternative to undifferentiated somatoform disorder for the somatizing patient in primary care
P478volume54

Reverse relations

cites work (P2860)
Q33586984A cross-sectional study of somatic symptoms and the identification of depression among elderly primary care patients
Q36012127A method for rating charts to identify and classify patients with medically unexplained symptoms.
Q39408480A qualitative analysis of explanatory models in medically unexplained physical symptoms presenting to a tertiary health care psychiatric facility in South India
Q34628285A randomized clinical trial of a care recommendation letter intervention for somatization in primary care
Q37231382A randomized trial of treatments for high-utilizing somatizing patients
Q45018799A symptom checklist to screen for somatoform disorders in primary care
Q35749591A systematic review of the epidemiology of somatisation disorder and hypochondriasis
Q51966527An age-based comparison of chronic pain clinic patients.
Q28395040An evaluation of SNOMED CT in the domain of complex chronic conditions
Q44241686Anxiety and mood disorders in otorhinolaryngology outpatients presenting with dizziness: validation of the self-administered PRIME-MD Patient Health Questionnaire and epidemiology
Q33579620Assessing medically unexplained symptoms: evaluation of a shortened version of the SOMS for use in primary care
Q48149252Changes in psychosocial well-being after mindfulness-based stress reduction: a prospective cohort study
Q92910679Childhood traumatization is associated with differences in TRPA1 promoter methylation in female patients with multisomatoform disorder with pain as the leading bodily symptom
Q35753038Classification and diagnosis of patients with medically unexplained symptoms
Q31156263Cognitive-affective neuroscience of somatization disorder and functional somatic syndromes: reconceptualizing the triad of depression-anxiety-somatic symptoms
Q51941538Cognitive-behavioural therapy for patients with multiple somatoform symptoms--a randomised controlled trial in tertiary care.
Q24235488Consultation letters for medically unexplained physical symptoms in primary care
Q34870074Coping style in primary care adult patients with abridged somatoform disorders.
Q40199886Current somatoform disorders in Norway: prevalence, risk factors and comorbidity with anxiety, depression and musculoskeletal disorders
Q51100104Depressive and anxiety disorders in patients presenting with physical complaints: clinical predictors and outcome.
Q80912828Determinants of complaint symptoms in a Swedish health care practice--results of a questionnaire survey
Q34385688Development of mental disorders one year after exposure to psychosocial stressors; a cohort study in primary care patients with a physical complaint.
Q37159383Diagnostic accuracy of predicting somatization from patients' ICD-9 diagnoses
Q51904094Diagnostic classification and demographic features in 283 patients with somatoform disorder.
Q35065268Differences between patients with chronic widespread pain and local chronic low back pain in primary care--a comparative cross-sectional analysis
Q33830179Dissociation of regional activity in default mode network in medication-naive, first-episode somatization disorder
Q37504661Economic evaluation of brief psychodynamic interpersonal therapy in patients with multisomatoform disorder
Q43736099Empirical foundations for the diagnosis of somatization: implications for DSM-5.
Q24671039Exploration of DSM-IV criteria in primary care patients with medically unexplained symptoms
Q33316371Follow-up study on health care use of patients with somatoform, anxiety and depressive disorders in primary care
Q21260313Frequency shifts in the anterior default mode network and the salience network in chronic pain disorder
Q60935160Frequent attenders in general medical practice in Italy: a preliminary report on clinical variables related to low functioning
Q74588436Frequent attenders without organic disease in a gastroenterology clinic. Patient characteristics and health care use
Q36485709Functional network connectivity of pain-related resting state networks in somatoform pain disorder: an exploratory fMRI study
Q26827990Health care utilization and poor reassurance: potential predictors of somatoform disorders
Q42677596Heartsink hotel, or "Oh no, look who's on my schedule this afternoon!".
Q92084319Hospitalized Patients with Medically Unexplained Physical Symptoms: Clinical Context and Economic Costs of Healthcare Management
Q39261979Long-Term Outcome of Bodily Distress Syndrome in Primary Care: A Follow-Up Study on Health Care Costs, Work Disability, and Self-Rated Health
Q48854147Magical thinking in somatoform disorders: an exploratory study among patients with suspected allergies
Q34706644Managing the consultation with patients with medically unexplained symptoms: a grounded theory study of supervisors and registrars in general practice
Q41685292Medically unexplained otorhinolaryngological symptoms: Towards integrated psychiatric care.
Q43158651Medically unexplained physical symptoms
Q24812281Medically unexplained physical symptoms in medical practice: a psychiatric perspective
Q35673073Medically unexplained physical symptoms: toward an alternative paradigm for diagnosis and treatment
Q34083702Medically unexplained symptoms: an epidemiological study in seven specialities.
Q39266990Mixed emotional and physical symptoms in general practice: what diagnoses do GPs use to describe them?
Q33630323Models of collaboration
Q47674919Moderating Effects of Alexithymia on Associations between the Therapeutic Alliance and the Outcome of Brief Psychodynamic-Interpersonal Psychotherapy for Multisomatoform Disorder
Q36090776Multiple somatic symptoms in primary care patients: a cross-sectional study of consultation content, clinical management strategy and burden of encounter
Q43856001Multisomatoform disorder: agreement between patient and physician report of criterion symptom explanation
Q38777582Neuroticism, alexithymia, negative affect and positive affect as predictors of medically unexplained symptoms in primary care
Q24188129Non-pharmacological interventions for somatoform disorders and medically unexplained physical symptoms (MUPS) in adults
Q24194323Non-pharmacological interventions for somatoform disorders and medically-unexplained physical symptoms (MUPS) in adults
Q33693340Patients presenting with somatic complaints in general practice: depression, anxiety and somatoform disorders are frequent and associated with psychosocial stressors
Q33286319Patients with persistent medically unexplained symptoms in general practice: characteristics and quality of care
Q24188067Pharmacological interventions for somatoform disorders in adults
Q24201668Pharmacological interventions for somatoform disorders in adults
Q33754222Physical "phantasies" and family functions: overcoming the mind/body dualism in somatization.
Q91591896Prevalence of medically unexplained symptoms in adults who are high users of health care services: a systematic review and meta-analysis protocol
Q44594234Prevalence of neurasthenia, comorbidity, and association with impairment among a nationally representative sample of US adults.
Q36112008Psychophysiologic treatment for patients with medically unexplained symptoms: a randomized controlled trial
Q35721847Ratings of physician communication by real and standardized patients
Q38768624Readiness to change as a moderator of therapy outcome in patients with somatoform disorders
Q35480179Reliability of self-reported diagnoses in patients with neurologically unexplained symptoms.
Q37642639Sensory neuromodulators in functional nausea and vomiting: predictors of response
Q24673207Should general psychiatry ignore somatization and hypochondriasis?
Q50637555Somatic symptom count scores do not identify patients with symptoms unexplained by disease: a prospective cohort study of neurology outpatients.
Q34229353Somatic symptom reporting in women and men
Q36416933Somatic symptoms and diseases are more common in women exposed to violence
Q24529944Somatic symptoms in women 11 years after the Chornobyl accident: prevalence and risk factors
Q37421483Somatisation and alexithymia in patients with high use of medical care and medically unexplained symptoms.
Q39982770Somatisation disorder and its associated factors in multiethnic primary care clinic attenders
Q41809652Somatisation in primary care. Solitary disclosure allows people to determine their own dose
Q24683093Somatization in Family Practice: Comparing 5 Methods of Classification
Q51079686Somatization in primary care: it's time for parity.
Q49068391Somatization is associated with physical health-related quality of life independent of anxiety and depression in cancer, glaucoma and rheumatological disorders
Q50675220Somatizing frequent attenders in primary health care.
Q27015698Somatoform abdominal pain in surgery: is SD worthy of surgical attention? Case reports and literature review
Q26829908Somatoform disorders and medically unexplained symptoms in primary care
Q36384136Somatoform disorders: perspectives from Pakistan
Q30559666Somatoform pain: a developmental theory and translational research review
Q47712204The Association of Sensory Responsiveness with Somatic Symptoms and Illness Anxiety
Q34224275The FIP study: a randomised, controlled trial of screening and recognition of psychiatric disorders
Q38924576The Heterogeneity of Illness Behaviors in Patients with Medically Unexplained Physical Symptoms
Q51951989The natural course of DSM-IV somatoform disorders and syndromes among adolescents and young adults: a prospective-longitudinal community study.
Q34724483The outcomes among patients presenting in primary care with a physical symptom at 5 years.
Q36059991The patient-physician relationship and medical utilization
Q51939182The presence of psychiatric disorders reduces the likelihood of neurologic disease among referrals to a neurology clinic.
Q51950582The somatization in primary care study: a tale of three diagnoses.
Q33630284The somatizing patient
Q74415690The value of screening for psychiatric disorders prior to upper endoscopy
Q44254783Topiramate as a treatment for pain in multisomatoform disorder patients: an open trial
Q47706603Toward empirically based criteria for the classification of somatoform disorders
Q33824414Towards a clinically useful diagnosis for mild-to-moderate conditions of medically unexplained symptoms in general practice: a mixed methods study.
Q36384105Towards better understanding and management of somatoform disorders
Q36554034True Vertigo Patients in Emergency Department; an Epidemiologic Study
Q73954851Unexplained symptoms in primary care: perspectives of doctors and patients
Q35678803Use of psychopharmacological agents for functional gastrointestinal disorders
Q51949455Using nurse practitioners to implement an intervention in primary care for high-utilizing patients with medically unexplained symptoms.
Q35742960Validation of the PHQ-15 for somatoform disorder in the occupational health care setting
Q36977472Validity of current somatoform disorder diagnoses: perspectives for classification in DSM-V and ICD-11.
Q52354032[Somatoform disorders with pain as the predominant symptom: results to distinguish a common group of diseases].

Search more.